D.E. Shaw & Co
STAA icon

D.E. Shaw & Co’s STAAR Surgical STAA Stock Holding History

D.E. Shaw & Co’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,100
Closed -$301K – 4694
2025
Q1 		$301K Buy
17,100
+7,000
+69% +$140K ﹤0.01% 3757
2024
Q4 		$245K Buy
+10,100
New +$288K ﹤0.01% 3991
2023
Q3 		– Sell
-30,500
Closed -$1.6M – 4480
2023
Q2 		$1.6M Sell
30,500
-47,700
-61% -$2.9M ﹤0.01% 2777
2023
Q1 		$5M Hold
78,200
– – 0.01% 1935
2022
Q4 		$3.8M Buy
+78,200
New +$4.9M ﹤0.01% 2351
2022
Q2 		– Sell
-14,300
Closed -$1.14M – 5753
2022
Q1 		$1.14M Sell
14,300
-43,200
-75% -$3.22M ﹤0.01% 3795
2021
Q4 		$5.25M Hold
57,500
– – ﹤0.01% 2317
2021
Q3 		$7.39M Buy
57,500
+15,400
+37% +$2.16M 0.01% 1763
2021
Q2 		$6.42M Buy
42,100
+10,000
+31% +$1.32M 0.01% 1843
2021
Q1 		$3.38M Buy
+32,100
New +$3.21M ﹤0.01% 2143
2019
Q1 		– Sell
-17,200
Closed -$549K – 3906
2018
Q4 		$549K Buy
+17,200
New +$670K ﹤0.01% 3043

Other funds holding STAA

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
YC
Yunqi Capital Hong Kong $92.4M AUM 16.3% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
Anatole Investment Management Central, Hong Kong $716M AUM 502.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co's STAA Position: Q1 2026 in Review

D.E. Shaw & Co increased its STAAR Surgical (STAA) stake by 58% in Q1 2026, buying an estimated $195K and bringing the position to 27,846 shares worth $521K. The position accounts for ﹤0.01% of the portfolio, ranked #3837.

D.E. Shaw & Co first reported a position in STAA in Q2 2013 and has held it in 35 quarters since. The position peaked at $12.8M in Q2 2018. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

  • D.E. Shaw & Co held 27,846 shares of STAAR Surgical worth $521K as of Q1 2026.
  • D.E. Shaw & Co bought 10,209 STAAR Surgical shares in Q1 2026, an estimated $195K.
  • STAAR Surgical made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3837 holding.
  • D.E. Shaw & Co first reported a position in STAAR Surgical in Q2 2013 and has held it in 35 quarters since.
  • D.E. Shaw & Co's STAAR Surgical position peaked at $12.8M in Q2 2018.
  • 187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.